期刊文献+

Lung carcinoma signaling pathways activated by smoking 被引量:1

Lung carcinoma signaling pathways activated by smoking
下载PDF
导出
摘要 Lung cancer is the leading cause of cancer death in men and women worldwide,with over a million deaths annually.Tobacco smoke is the major etiologic risk factor for lung cancer in current or previous smokers and has been strongly related to certain types of lung cancer,such as small cell lung carcinoma and squamous cell lung carcinoma.In recent years,there has been an increased incidence of lung adenocarcinoma.This change is strongly associated with changes in smoking behavior and cigarette design.Carcinogens present in tobacco products and their intermediate metabolites can activate multiple signaling pathways that contribute to lung cancer carcinogenesis.In this review,we summarize the smoking-activated signaling pathways involved in lung cancer. Lung cancer is the leading cause of cancer death in men and women worldwide, with over a million deaths annually. Tobacco smoke is the major etiologic risk factor for lung cancer in current or previous smokers and has been strongly related to certain types of lung cancer, such as small cell lung carcinoma and squamous cell lung carcinoma. In recent years, there has been an increased incidence of lung adenocarcinoma. This change is strongly associated with changes in smoking behavior and cigarette design. Carcinogens present in tobacco products and their intermediate metabolites can activate multiple signaling pathways that contribute to lung cancer carcinogenesis. In this review, we summarize the smoking-activated signaling pathways involved in lung cancer.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 北大核心 2011年第8期551-558,共8页
基金 supported by a fellowship from China Education Council
关键词 信号通路 吸烟者 肺癌 激活 死亡人数 危险因素 烟草烟雾 吸烟行为 Lung cancer, signaling pathways, carcinogenesis, cigarette smoking
  • 相关文献

参考文献74

  • 1Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007 [J]. CA Cancer J Clin, 2007,57(1):43-66.
  • 2Alberg A J, Ford JG, Samet JM, et al. Epidemiology of lung cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd edition) [J]. Chest, 2007,132(3 Suppl):29S-55S.
  • 3Brambilla E, Travis WD, Colby TV, et al, The new World Health Organization classification of lung tumours [J]. Eur Respir J, 2001,18(6): 1059-1068.
  • 4Herbst RS, Heymach JV, Lippman SM. Lung cancer [J]. N Engl J Med, 2008,359(13):1367-1380.
  • 5Thun M J, Lally CA, Flannery JT, et al. Cigarette smoking and changes in the histopathology of lung cancer [J]. J Natl Cancer Inst, 1997,89(21): 1580-1586.
  • 6Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers--a different disease [J]. Nat Rev Cancer, 2007,7(10):778-790.
  • 7Schuller HM, Tithof PK, Williams M, et al. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-l-butanone is a beta-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via beta-adrenergic receptor-mediated release of arachidonic acid [J]. Cancer Res, 1999,59(18):4510-4515.
  • 8Barnes PJ. Beta-adrenergic receptors and their regulation [J]. Am J Respir Crit Care Med, 1995,152(3):838-860.
  • 9Schuller HM. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development [J]. Nat Rev Cancer, 2002,2(6):455-463.
  • 10El-Bayoumy K, latropoulos M, Amin S, et al. Increased expression of cyclooxygenase-2 in rat lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-4-(3- pyridyl)-1-butanone: the impact of a high-fat diet [J]. Cancer Res, 1999,59(7):1400-1403.

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部